845 related articles for article (PubMed ID: 18599808)
1. Concise review: mesenchymal stromal cells: potential for cardiovascular repair.
Psaltis PJ; Zannettino AC; Worthley SG; Gronthos S
Stem Cells; 2008 Sep; 26(9):2201-10. PubMed ID: 18599808
[TBL] [Abstract][Full Text] [Related]
2. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.
Martin-Rendon E; Sweeney D; Lu F; Girdlestone J; Navarrete C; Watt SM
Vox Sang; 2008 Aug; 95(2):137-48. PubMed ID: 18557828
[TBL] [Abstract][Full Text] [Related]
3. Enrichment for STRO-1 expression enhances the cardiovascular paracrine activity of human bone marrow-derived mesenchymal cell populations.
Psaltis PJ; Paton S; See F; Arthur A; Martin S; Itescu S; Worthley SG; Gronthos S; Zannettino AC
J Cell Physiol; 2010 May; 223(2):530-40. PubMed ID: 20162565
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro.
Rose RA; Jiang H; Wang X; Helke S; Tsoporis JN; Gong N; Keating SC; Parker TG; Backx PH; Keating A
Stem Cells; 2008 Nov; 26(11):2884-92. PubMed ID: 18687994
[TBL] [Abstract][Full Text] [Related]
5. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views.
Phinney DG; Prockop DJ
Stem Cells; 2007 Nov; 25(11):2896-902. PubMed ID: 17901396
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells and their potential as cardiac therapeutics.
Pittenger MF; Martin BJ
Circ Res; 2004 Jul; 95(1):9-20. PubMed ID: 15242981
[TBL] [Abstract][Full Text] [Related]
7. Immune plasticity of bone marrow-derived mesenchymal stromal cells.
Stagg J; Galipeau J
Handb Exp Pharmacol; 2007; (180):45-66. PubMed ID: 17554504
[TBL] [Abstract][Full Text] [Related]
8. Trafficking and differentiation of mesenchymal stem cells.
Liu ZJ; Zhuge Y; Velazquez OC
J Cell Biochem; 2009 Apr; 106(6):984-91. PubMed ID: 19229871
[TBL] [Abstract][Full Text] [Related]
9. Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy.
Haack-Sorensen M; Friis T; Bindslev L; Mortensen S; Johnsen HE; Kastrup J
Scand J Clin Lab Invest; 2008; 68(3):192-203. PubMed ID: 17852829
[TBL] [Abstract][Full Text] [Related]
10. Comparison of in vitro chondrogenic potential of human mesenchymal stem cells derived from bone marrow and adipose tissue.
Danisovic L; Varga I; Polák S; Ulicná M; Hlavacková L; Böhmer D; Vojtassák J
Gen Physiol Biophys; 2009 Mar; 28(1):56-62. PubMed ID: 19390137
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction, and production of conditioned medium.
Gnecchi M; Melo LG
Methods Mol Biol; 2009; 482():281-94. PubMed ID: 19089363
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells: isolation, in vitro expansion and characterization.
Beyer Nardi N; da Silva Meirelles L
Handb Exp Pharmacol; 2006; (174):249-82. PubMed ID: 16370331
[TBL] [Abstract][Full Text] [Related]
13. Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation.
Reinders ME; Fibbe WE; Rabelink TJ
Nephrol Dial Transplant; 2010 Jan; 25(1):17-24. PubMed ID: 19861311
[TBL] [Abstract][Full Text] [Related]
14. The use of mesenchymal (skeletal) stem cells for treatment of degenerative diseases: current status and future perspectives.
Abdallah BM; Kassem M
J Cell Physiol; 2009 Jan; 218(1):9-12. PubMed ID: 18726996
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cell homing capacity.
Sordi V
Transplantation; 2009 May; 87(9 Suppl):S42-5. PubMed ID: 19424004
[TBL] [Abstract][Full Text] [Related]
16. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine.
Caplan AI
J Cell Physiol; 2007 Nov; 213(2):341-7. PubMed ID: 17620285
[TBL] [Abstract][Full Text] [Related]
17. Isolation, culture, and differentiation potential of mouse marrow stromal cells.
Anjos-Afonso F; Bonnet D
Curr Protoc Stem Cell Biol; 2008 Oct; Chapter 2():Unit 2B.3. PubMed ID: 18972375
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells for bone repair: preclinical studies and potential orthopedic applications.
Arinzeh TL
Foot Ankle Clin; 2005 Dec; 10(4):651-65, viii. PubMed ID: 16297825
[TBL] [Abstract][Full Text] [Related]
19. CD45-positive cells of haematopoietic origin enhance chondrogenic marker gene expression in rat marrow stromal cells.
Ahmed N; Vogel B; Rohde E; Strunk D; Grifka J; Schulz MB; Grässel S
Int J Mol Med; 2006 Aug; 18(2):233-40. PubMed ID: 16820929
[TBL] [Abstract][Full Text] [Related]
20. From bone marrow to therapeutic applications: different behaviour and genetic/epigenetic stability during mesenchymal stem cell expansion in autologous and foetal bovine sera?
Tonti GA; Mannello F
Int J Dev Biol; 2008; 52(8):1023-32. PubMed ID: 18956335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
